Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.

Schiffman M, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Apple R, Aldrich C, Erlich HA, Tam T, Befano B, Burk RD, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1304-10. doi: 10.1158/1055-9965.EPI-14-1353. Epub 2015 Jun 18.

2.

A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening results.

Schiffman M, Burk RD, Boyle S, Raine-Bennett T, Katki HA, Gage JC, Wentzensen N, Kornegay JR, Aldrich C, Tam T, Erlich H, Apple R, Befano B, Castle PE.

J Clin Microbiol. 2015 Jan;53(1):52-9. doi: 10.1128/JCM.02116-14. Epub 2014 Oct 22.

3.

Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique.

Menéndez C, Castellsagué X, Renom M, Sacarlal J, Quintó L, Lloveras B, Klaustermeier J, Kornegay JR, Sigauque B, Bosch FX, Alonso PL.

Infect Dis Obstet Gynecol. 2010;2010. pii: 609315. doi: 10.1155/2010/609315. Epub 2010 Jul 11.

4.

Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA.

Wilkinson DE, Baylis SA, Padley D, Heath AB, Ferguson M, Pagliusi SR, Quint WG, Wheeler CM; Collaborative Study Group.

Int J Cancer. 2010 Jun 15;126(12):2969-83. doi: 10.1002/ijc.25039.

5.

Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia.

Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy Ad, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Kornegay JR, Franco E; HIPVIRG Study Group, Coutlée F.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):32-9. doi: 10.1097/QAI.0b013e318183a905.

PMID:
18667921
6.

Mouthwash as a low-cost and safe specimen transport medium for human papillomavirus DNA testing of cervicovaginal specimens.

Castle PE, Sadorra M, Garcia FA, Cullen AP, Lorincz AT, Mitchell AL, Whitby D, Chuke R, Kornegay JR.

Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):840-3.

7.

Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S; Canadian Women's HIV study Group, Franco E.

J Clin Microbiol. 2006 Jun;44(6):1998-2006.

8.

Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in Mexico.

Vaccarella S, Lazcano-Ponce E, Castro-Garduño JA, Cruz-Valdez A, Díaz V, Schiavon R, Hernández P, Kornegay JR, Hernández-Avila M, Franceschi S.

Int J Cancer. 2006 Oct 15;119(8):1934-9.

9.

Human papillomavirus in men: comparison of different genital sites.

Aguilar LV, Lazcano-Ponce E, Vaccarella S, Cruz A, Hernández P, Smith JS, Muñoz N, Kornegay JR, Hernández-Avila M, Franceschi S.

Sex Transm Infect. 2006 Feb;82(1):31-3.

10.

Self-sampling versus physician-sampling for human papillomavirus testing.

Agorastos T, Dinas K, Lloveras B, Font R, Kornegay JR, Bontis J, de Sanjose S.

Int J STD AIDS. 2005 Nov;16(11):727-9.

PMID:
16303065
11.

Evaluation of a modified reverse line blot assay for detection and typing of human papillomavirus.

Tabrizi SN, Stevens M, Chen S, Rudland E, Kornegay JR, Garland SM.

Am J Clin Pathol. 2005 Jun;123(6):896-9.

PMID:
15899782
12.

Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.

Agorastos T, Dinas K, Lloveras B, de Sanjose S, Kornegay JR, Bonti H, Bosch FX, Constantinidis T, Bontis J.

Gynecol Oncol. 2005 Mar;96(3):714-20.

PMID:
15721416
13.

Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece.

Agorastos T, Dinas K, Lloveras B, Bosch FX, Kornegay JR, Bontis JN, de Sanjose S.

Eur J Cancer Prev. 2004 Apr;13(2):145-7.

PMID:
15100583
14.

Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR.

Aho J, Kornegay JR, Healey S, Roger M, Dion F, Gaudreault D, Shepard AP, Franco EL, Coutlée F.

J Clin Virol. 2004 Feb;29(2):127-33.

PMID:
14747032
15.

Human papillomavirus infection in men attending a sexually transmitted disease clinic.

Baldwin SB, Wallace DR, Papenfuss MR, Abrahamsen M, Vaught LC, Kornegay JR, Hallum JA, Redmond SA, Giuliano AR.

J Infect Dis. 2003 Apr 1;187(7):1064-70. Epub 2003 Mar 7.

PMID:
12660920
16.
17.

Human papillomavirus genotypes in rural Mozambique.

Castellsagué X, Menéndez C, Loscertales MP, Kornegay JR, dos Santos F, Gómez-Olivé FX, Lloveras B, Abarca N, Vaz N, Barreto A, Bosch FX, Alonso P.

Lancet. 2001 Oct 27;358(9291):1429-30.

PMID:
11705494
18.

Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format.

Kornegay JR, Shepard AP, Hankins C, Franco E, Lapointe N, Richardson H, Coutleé F; Canadian Women's HIV Study Group.

J Clin Microbiol. 2001 Oct;39(10):3530-6.

19.

Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.

Gravitt PE, Lacey JV Jr, Brinton LA, Barnes WA, Kornegay JR, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino R, Hildesheim A.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):95-100.

20.

Supplemental Content

Loading ...
Support Center